Patent application number | Description | Published |
20110264586 | SYSTEM AND METHOD FOR MULTIPATH CONTACTLESS TRANSACTIONS - A system for multipath contactless transaction processing, comprising a point-of-sale system comprising a processing unit and a video screen, the video screen at least sometimes viewable by a purchaser interacting with the point-of-sale processing system, wherein, during a transaction, a graphical indicia is displayed on the video screen in a form suitable for photographing or scanning by a device held by the purchaser, and wherein, upon receipt by the point-of-sale processing unit of at least one non-graphical indicia the content of which is determined at least in part by the contents of the graphical indicia that was displayed to the purchaser, the point-of-sale completes the transaction. | 10-27-2011 |
20110276402 | SYSTEMS AND METHODS FOR INTERACTIVE MERCHANDISING USING MULTIPATH CONTACTLESS COMMUNICATIONS - A system for interactive merchandising, comprising a server accessible via a data network to a mobile device and a graphical indicia displayed in a public location and associated with one or more nearby items, wherein, on receiving, at the server, a message from the mobile device comprising information based at least in part on the graphical indicia, the server determines a location of the mobile device and transmits information determined at least in part based on the graphical indicia and the location of the mobile device to the mobile device. | 11-10-2011 |
20120037697 | System and method for using machine-readable indicia to provide additional information and offers to potential customers - A system for using machine-readable indicia to provide additional information and offers to potential customers, the system comprising a network-connected server adapted to receive coded information from mobile devices, a database coupled to the server and containing data pertaining to products, a software application executing on the server for processing the coded information, and a plurality of labels containing machine-readable indicia and posted near products for sale, is disclosed. According to the invention, on receiving coded information from a mobile device, the server provides the data to the software application, and the software application determines from the coded information a location from which the information was obtained and a product to which the information pertains, and, based at least in part on the location and product information obtained, the application obtains additional data from the database and sends it to the mobile device from which the coded information was received. | 02-16-2012 |
20130227594 | SYSTEMS AND METHODS FOR AN ENHANCED, STEGANOGRAPHIC, EMBEDDED SECURE TRANSACTION SYSTEM - A system for multipath contactless transaction processing, comprising a networked server comprising a processing unit, a billing entity based on a first networked computing device comprising a processing unit and a video feed, the feed interloping a television broadcast video signal, the signal made available to potential purchasers to watch, wherein, during said viewing, a cue is provided whenever a transaction or interaction is available for scanning by a mobile device, and wherein, the user is prompted accordingly to act upon using the device. | 08-29-2013 |
Patent application number | Description | Published |
20140177680 | WIRELESS LINK TO TRANSMIT DIGITAL AUDIO DATA BETWEEN DEVICES IN A MANNER CONTROLLED DYNAMICALLY TO ADAPT TO VARIABLE WIRELESS ERROR RATES - A communication system including a host transceiver, one or many device transceivers, and a wireless or wired link, in which encoded digital audio data and optionally also other auxiliary data are transmitted and received between the host transceiver and one or many device transceivers. The wireless link can but need not be a Certified Wireless USB (“CWUSB”) link, which utilizes WiMedia Ultra-Wideband (“UWB”) radio technology. For certain embodiments, packets of encoded audio data are transmitted from a host to a device or multiple devices over the wireless link utilizing a variety of data packet transfer methods, with the host adapting its algorithms dynamically to provide the digital audio content over a changing wireless error rate environment. The host intelligently controls the method of data transmission, including data encoding format, synchronization, latency, and transmission rate, in response to data transfer error information it detects or receives from each individual device in the system. Other embodiments are devices that employ audio-data-specific error concealment methods. Other embodiments concern host and device management of graceful muting and restart of audio on a device-by-device basis. | 06-26-2014 |
20140328506 | METHODS AND SYSTEMS TO PROVIDE AUTOMATIC CONFIGURATION OF WIRELESS SPEAKERS - Methods and systems for automatic configuration of wireless speakers are disclosed. A system is described whereby a wireless speaker is configured to use an audio tone to generate a sound wave. The sound wave is received by an audio input/output device, which uses the received sound wave to generate audio information. A processor is configured to use the audio information to determine a distance between the wireless speaker and the audio input/output device, and to configure an audio parameter of the wireless speaker as a function of the distance. | 11-06-2014 |
20150043888 | AUTO-SELECT ALGORITHM FOR A HIGH-DEFINITION MULTIMEDIA INTERFACE SWITCH - A multimedia device is described. The multimedia device includes a multiplexer. The multimedia device also includes a plurality of high-definition interface inputs coupled with the multiplexer and an output coupled with the multiplexer. Moreover, the multimedia device includes a processor coupled with the multiplexer to configure the multiplexer to provide one of the plurality of high definition multimedia interface inputs to the output based on the detection of a clock signal on one of the plurality of high-definition multimedia interface inputs. Furthermore, methods related to embodiments of a multimedia device are described herein. | 02-12-2015 |
Patent application number | Description | Published |
20080226018 | CONTRAST-ENHANCED CONE BEAM X-RAY IMAGING, EVALUATION, MONITORING AND TREATMENT DELIVERY - A method of imaging a patient's uncompressed region of interest using X-ray cone beam computed tomography or cone beam digital tomography comprises the step of introducing an effective amount of a contrast agent to the uncompressed region of interest. A system for imaging a patient's uncompressed region of interest using cone beam computed tomography (CBCT) or cone beam digital tomography (CBDT) comprises an X-ray source transmitting an X-ray to the uncompressed region of interest, an image acquisition system acquiring a plurality of two-dimensional projection images data for a CBCT or CBDT data set with at least one of the projection images acquired in 35 milliseconds or less, and a processor generating a three-dimensional computed tomography image data set resolving voxels with dimensions of 0.4 mm or less in at least two orthogonal directions. | 09-18-2008 |
20090087045 | CANCER DETECTION, DIAGNOSIS, STAGING, TREATMENT PLANNING, DELIVERY, AND MONITORING USING X-RAY ATTENUATION COEFFICIENT DISTRIBUTIONS - A method of analyzing a volumetric data set obtained by an imaging system from an object is provided includes defining a first region of interest comprising a population of voxels of a first tissue part of the object to obtain a first distribution of radiation attenuation coefficient values, defining a second region of interest comprising a sample of voxels of a second tissue part of the object to obtain a second distribution of radiation attenuation coefficient values, and distinguishing the second tissue from the first tissue using the properties of the first and second distributions of radiation attenuation coefficients. | 04-02-2009 |
20100016649 | External Beam Radiotherapy And Imaging With Radioactive Isotope - A method of delivering external radiation beams to a target volume in a body portion includes positioning a radioactive isotope source at a plurality of locations spaced apart around the body portion, and collimating radiation beams of the radioactive isotope source from the plurality of locations, whereby the target volume in the body portion is deposited with a predetermined dose distribution. A radiation device employs a member having a configuration adapted to surround a body portion to be irradiated. The member has a channel and a plurality of collimators spaced apart along and coupled to the channel. The plurality of collimators define a plurality of dwelling locations for a radioactive isotope source in the channel and are configured to collimate radiation beams of the radioactive isotope source. | 01-21-2010 |
Patent application number | Description | Published |
20080292055 | METHOD FOR COMPUTING PATIENT RADIATION DOSE IN COMPUTED TOMOGRAPHY - A system and method are disclosed for computing a radiation dose delivered to a patient during a computed tomography (CT) scan of the patient. The CT image dataset generated during the scan of the patient, and one or more parameters relating to a x-ray source are used to calculate the radiation dose delivered to the patient as a function of the CT image data set and the one or more parameters of the x-ray source. The radiation dose is generally found by calculating a primary x-ray dose distribution and scattered x-ray dose distribution from the CT image dataset and taking the sum of the primary x-ray dose distribution and scattered x-ray dose distribution. | 11-27-2008 |
20130016808 | APPARATUS AND METHODS FOR DETERMINATION OF THE HALF VALUE LAYER OF X-RAY BEAMS - Described is an apparatus for use in HVL measurement as well as methods of making measurements. One version of the apparatus is a cage structure having a central axis and a central opening defined by a filter encircling the central axis, with the filter having a thickness that varies peripherally around said central axis. The filter can be formed from multiple spaced-apart plates having varying thicknesses or can be formed from a cylinder having a continuously increasing thickness. | 01-17-2013 |
20130071334 | METHOD AND SYSTEM FOR IDENTIFYING, ASSESSING, AND MANAGING CANCER DISEASE - Techniques described herein generally relate to identifying, assessing, and managing cancer diseases. Some example methods may include constructing one or more quantitative metrics for the cancer disease in a selected population of other patients retrieved during the scheduling interval, acquiring a first set of numeric biomarker data for the patient before having placed a biomarker in the patient, acquiring a second set of numeric biomarker data for the patient after having placed the biomarker in the patient, identifying one or more nodules from the first set of numeric biomarker data and the second set of numeric biomarker data, wherein each of the one or more nodules is characterized by a mean numeric biomarker difference value derived from the first set of numeric biomarker data and the second set of numeric biomarker data, and predicting quantitative and objective risk for the one or more nodules based on the mean numeric biomarker difference value and at least one of the one or more quantitative metrics. | 03-21-2013 |
Patent application number | Description | Published |
20090041784 | Compositions and methods relating to glucagon receptor antibodies - The present disclosure provides compositions and methods relating to antigen binding proteins, in particular, antibodies which specifically bind to the human glucagon receptor. The disclosure provides nucleic acids encoding such antigen binding proteins and antibodies and methods of making and using such antibodies including methods of treating and preventing type 2 diabetes and related disorders by administering such antibodies to a subject in need of such treatment. | 02-12-2009 |
20100168020 | STABILIZED RECEPTOR POLYPEPTIDES AND USES THEREOF - The present invention provides stabilized activin IIB receptor polypeptides and proteins capable of binding and inhibiting the activities of activin A, myostatin, or GDF-11. The present invention also provides polynucleotides, vectors and host cells capable of producing the stabilized polypeptides and proteins. Compositions and methods for treating muscle-wasting diseases and metabolic disorders are also provided. | 07-01-2010 |
20100172895 | Human CGRP Receptor Binding Proteins - Antigen binding proteins that bind to human CGRP receptor (CGRP R) are provided. Nucleic acids encoding the antigen binding protein, vectors, and cells encoding the same are also provided. The antigen binding proteins can inhibit binding of CGRP R to CGRP, and are useful in a number of CGRP R related disorders, including the treatment and/or prevention of migraine headaches. | 07-08-2010 |
20100240582 | Peptides and related molecules that modulate nerve growth factor activity - The present invention relates to certain biologically active peptides and polypeptides which can be used as therapeutics or prophylactics against diseases or disorders linked to NGF as the causative agent. In one aspect of the present invention, pharmacologically active polypeptides comprising peptides linked to one or more Fc domains are provided. | 09-23-2010 |
20110223160 | COMPOSITIONS AND METHODS RELATING TO GLUCAGON RECEPTOR ANTIBODIES - The present disclosure provides compositions and methods relating to antigen binding proteins, in particular, antibodies which specifically bind to the human glucagon receptor. The disclosure provides nucleic acids encoding such antigen binding proteins and antibodies and methods of making and using such antibodies including methods of treating and preventing type 2 diabetes and related disorders by administering such antibodies to a subject in need of such treatment. | 09-15-2011 |
20120034237 | Antibodies directed to angiopoietin-1 and angiopoietin-2 and uses thereof - Disclosed are specific binding agents, such as fully human antibodies, that bind to angiopoietin 1 and/or angiopoietin-2. Also disclosed are heavy chain fragments, light chain fragments, and CDRs of the antibodies, as well as methods of making and using the antibodies. | 02-09-2012 |
20120121591 | SELECTIVE AND POTENT PEPTIDE INHIBITORS OF Kv1.3 - Disclosed are compositions of matter having an amino acid sequence of SEQ ID NO:4, or a pharmaceutically acceptable salt thereof, including embodiments comprising a toxin peptide analog related to ShK, HmK, and AETX-K and pharmaceutical compositions or medicaments containing them along with a pharmaceutically acceptable carrier. Some embodiments include a half-life extending moiety. Also disclosed are a method of preventing or mitigating a relapse of a symptom of multiple sclerosis and a method of treating an autoimmune disorder using the compositions. | 05-17-2012 |
20120129771 | PEPTIDES AND RELATED MOLECULES THAT MODULATE NERVE GROWTH FACTOR ACTIVITY - The present invention relates to certain biologically active peptides and polypeptides which can be used as therapeutics or prophylactics against diseases or disorders linked to NGF as the causative agent. In one aspect of the present invention, pharmacologically active polypeptides comprising peptides linked to one or more Fc domains are provided. | 05-24-2012 |
20120195879 | CARRIER IMMUNOGLOBULINS AND USES THEREOF - Disclosed is an isolated antigen binding protein, such as but not limited to, an antibody or antibody fragment. Also disclosed are pharmaceutical compositions and medicaments comprising the antigen binding protein, isolated nucleic acid encoding it, vectors, host cells, and hybridomas useful in methods of making it. In some embodiments the antigen binding protein comprises one to twenty-four pharmacologically active chemical moieties conjugated thereto, such as a pharmacologically active polypeptide. | 08-02-2012 |
20120258122 | Antibodies Directed to Angiopoietin-1 and Angiopoietin-2 and Uses Thereof - Disclosed are specific binding agents, such as fully human antibodies, that bind to angiopoietin 1 and/or angiopoietin-2. Also disclosed are heavy chain fragments, light chain fragments, and CDRs of the antibodies, as well as methods of making and using the antibodies. | 10-11-2012 |
20130071410 | Human CGRP Receptor Binding Proteins - Antigen binding proteins that bind to human CGRP receptor (CGRP R) are provided. Nucleic acids encoding the antigen binding protein, vectors, and cells encoding the same are also provided. The antigen binding proteins can inhibit binding of CGRP R to CGRP, and are useful in a number of CGRP R related, disorders including the treatment and/or prevention of migraine headaches. | 03-21-2013 |
20130225484 | STABILIZED RECEPTOR POLYPEPTIDES AND USES THEREOF - The present invention provides stabilized activin IIB receptor polypeptides and proteins capable of binding and inhibiting the activities of activin A, myostatin, or GDF-11. The present invention also provides polynucleotides, vectors and host cells capable of producing the stabilized polypeptides and proteins. Compositions and methods for treating muscle-wasting diseases and metabolic disorders are also provided. | 08-29-2013 |
20140099670 | RANKL ANTIBODY-PTH/PTHrP CHIMERIC MOLECULES - Chimeric molecules comprising receptor activator of NF-κB ligand (RANKL) antibodies and parathyroid hormone/parathyroid hormone-related protein (PTH/PTHrP) peptides are described. Compositions and methods for the treatment of bone diseases are also described. | 04-10-2014 |
20150376286 | HUMAN CGRP RECEPTOR BINDING PROTEINS - Antigen binding proteins that bind to human CGRP receptor (CGRP R) are provided. Nucleic acids encoding the antigen binding protein, vectors, and cells encoding the same are also provided. The antigen binding proteins can inhibit binding of CGRP R to CGRP, and are useful in a number of CGRP R related disorders, including the treatment and/or prevention of migraine headaches. | 12-31-2015 |
Patent application number | Description | Published |
20080213277 | HEPCIDIN, HEPCIDIN ANTAGONISTS AND METHODS OF USE - The invention relates to purified, correctly folded hepcidin, antibodies that bind hepcidin, and methods of making and using such materials. Also provide are methods of treated hepcidin-related disorders. | 09-04-2008 |
20090220491 | Binding agents which inhibit myostatin - The present invention provides binding agents comprising peptides capable of binding myostatin and inhibiting its activity. In one embodiment the binding agent comprises at least one myostatin-binding peptide attached directly or indirectly to at least one vehicle such as a polymer or an Fc domain. The binding agents of the present invention produced increased lean muscle mass when administered to animals and decreased fat to muscle ratios. Therapeutic compositions containing the binding agents of the present invention are useful for treating muscle-wasting disorders and metabolic disorders including diabetes and obesity. | 09-03-2009 |
20100330072 | Myostatin binding agents - The present invention provides binding agents comprising peptides capable of binding myostatin and inhibiting its activity. In one embodiment the binding agent comprises at least one myostatin-binding peptide attached directly or indirectly to at least one vehicle such as a polymer or an Fc domain. The binding agents of the present invention produced increased lean muscle mass when administered to animals and decreased fat to muscle ratios. Therapeutic compositions containing the binding agents of the present invention are useful for treating muscle-wasting disorders and metabolic disorders including diabetes and obesity. | 12-30-2010 |
20120083442 | MYOSTATIN BINDING AGENTS - The present invention provides binding agents comprising peptides capable of binding myostatin and inhibiting its activity. In one embodiment the binding agent comprises at least one myostatin-binding peptide attached directly or indirectly to at least one vehicle such as a polymer or an Fc domain. The binding agents of the present invention produced increased lean muscle mass when administered to animals and decreased fat to muscle ratios. Therapeutic compositions containing the binding agents of the present invention are useful for treating muscle-wasting disorders and metabolic disorders including diabetes and obesity. | 04-05-2012 |
20130230515 | MYOSTATIN BINDING AGENTS - The present invention provides binding agents comprising peptides capable of binding myostatin and inhibiting its activity. In one embodiment the binding agent comprises at least one myostatin-binding peptide attached directly or indirectly to at least one vehicle such as a polymer or an Fc domain. The binding agents of the present invention produced increased lean muscle mass when administered to animals and decreased fat to muscle ratios. Therapeutic compositions containing the binding agents of the present invention are useful for treating muscle-wasting disorders and metabolic disorders including diabetes and obesity. | 09-05-2013 |
20130336992 | ANTIBODIES DIRECTED TO ANGIOPOIETIN-1 AND ANGIOPOIETIN-2 AND USES THEREOF - Disclosed are specific binding agents, such as fully human antibodies, that bind to angiopoietin 1 and/or angiopoietin-2. Also disclosed are heavy chain fragments, light chain fragments, and CDRs of the antibodies, as well as methods of making and using the antibodies. | 12-19-2013 |
20140273089 | Fibroblast Growth Factor Receptor-Like Molecules and Uses Thereof - The present invention provides Fibroblast Growth Factor Receptor-Like (FGFR-L) polypeptides and nucleic acid molecules encoding the same. The invention also provides selective binding agents, vectors, host cells, and methods for producing FGFR-L polypeptides. The inventio further provides pharmaceutical compositions and methods for the diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with FGFR-L polypeptides. | 09-18-2014 |
20140286953 | HEPCIDIN, HEPCIDIN ANTAGONISTS AND METHODS OF USE - The invention relates to purified, correctly folded hepcidin, antibodies that bind hepcidin, and methods of making and using such materials. Also provide are methods of treated hepcidin-related disorders. | 09-25-2014 |
20150044235 | CARRIER IMMUNOGLOBULINS - Disclosed is an isolated antigen binding protein, such as but not limited to, an antibody or antibody fragment. Also disclosed are pharmaceutical compositions and medicaments comprising the antigen binding protein, isolated nucleic acid encoding it, vectors, host cells, and hybridomas useful in methods of making it. In some embodiments the antigen binding protein comprises one to twenty-four pharmacologically active chemical moieties conjugated thereto, such as a pharmacologically active polypeptide. | 02-12-2015 |
20150044236 | CARRIER IMMUNOGLOBULINS - Disclosed is an isolated antigen binding protein, such as but not limited to, an antibody or antibody fragment. Also disclosed are pharmaceutical compositions and medicaments comprising the antigen binding protein, isolated nucleic acid encoding it, vectors, host cells, and hybridomas useful in methods of making it. In some embodiments the antigen binding protein comprises one to twenty-four pharmacologically active chemical moieties conjugated thereto, such as a pharmacologically active polypeptide. | 02-12-2015 |
20150175687 | MYOSTATIN BINDING AGENTS - The present invention provides binding agents comprising peptides capable of binding myostatin and inhibiting its activity. In one embodiment the binding agent comprises at least one myostatin-binding peptide attached directly or indirectly to at least one vehicle such as a polymer or an Fc domain. The binding agents of the present invention produced increased lean muscle mass when administered to animals and decreased fat to muscle ratios. Therapeutic compositions containing the binding agents of the present invention are useful for treating muscle-wasting disorders and metabolic disorders including diabetes and obesity. | 06-25-2015 |